Compare ZVRA & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZVRA | AAM |
|---|---|---|
| Founded | 2006 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.9M | 467.9M |
| IPO Year | 2015 | 2024 |
| Metric | ZVRA | AAM |
|---|---|---|
| Price | $8.65 | $10.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.71 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 30.6K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | 0.33 |
| Revenue | ★ $84,388,000.00 | N/A |
| Revenue This Year | $336.43 | N/A |
| Revenue Next Year | $54.26 | N/A |
| P/E Ratio | ★ $16.12 | $32.04 |
| Revenue Growth | ★ 244.60 | N/A |
| 52 Week Low | $6.19 | $10.05 |
| 52 Week High | $13.16 | $10.79 |
| Indicator | ZVRA | AAM |
|---|---|---|
| Relative Strength Index (RSI) | 43.13 | 52.30 |
| Support Level | $8.12 | $10.56 |
| Resistance Level | $8.75 | $10.64 |
| Average True Range (ATR) | 0.51 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 33.21 | 28.57 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
AA Mission Acquisition Corp is a blank check company.